No photo of Arthur Vandenbark

View Scopus Profile

Arthur Vandenbark

Professor

  • 13280 Citations
  • 59 h-Index
1974 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Arthur Vandenbark is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

BLR&D Research Career Scientist Award Application

Vandenbark, A.

Project: Research project

Development of DR?1-MOG-35-55 for treatment of DR2 negative MS subjects

Vandenbark, A.

National Institutes of Health

2/1/16 → 1/31/17

Project: Research project

    • Immunoregulation of Myelin Specific T Lymphocytes

    Vandenbark, A.

    National Institutes of Health

    4/1/09 → 12/31/16

    Project: Research project

    • REGULATION OF EAE WITH RECOMBINANT TCR LIGANDS

    Vandenbark, A.

    National Institutes of Health

    12/1/03 → 3/31/16

    Project: Research project

    • Development of a T cell specific multiple sclerosis drug

    Vandenbark, A.

    National Institutes of Health

    9/30/03 → 8/31/07

    Project: Research project

    • Research Output

    Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C–C motif) ligand 2 levels in rats

    Loftis, J. M., Navis, T., Taylor, J., Hudson, R., Person, U., Lattal, K. M., Vandenbark, A. A., Shirley, R. & Huckans, M., Aug 5 2020, In : European Journal of Pharmacology. 880, 173175.

    Research output: Contribution to journal › Article

    • Spleen participation in partial MHC class II construct neuroprotection in stroke

    Brown, J., Kingsbury, C., Lee, J. Y., Vandenbark, A. A., Meza-Romero, R., Offner, H. & Borlongan, C. V., Jul 1 2020, In : CNS Neuroscience and Therapeutics. 26, 7, p. 663-669 7 p.

    Research output: Contribution to journal › Review article

    Open Access

    • Surviving the storm: Dealing with COVID-19

    Vandenbark, A. A., Meza-Romero, R. & Offner, H., Aug 2020, In : Cellular Immunology. 354, 104153.

    Research output: Contribution to journal › Letter

    A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury

    Vandenbark, A. A., Meza-Romero, R., Benedek, G. & Offner, H., Jan 23 2019, In : Journal of Neuroinflammation. 16, 1, 14.

    Research output: Contribution to journal › Review article

    • 4 Scopus citations

    A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental Stroke

    Lee, J. Y., Castelli, V., Bonsack, B., Coats, A. B., Navarro-Torres, L., Garcia-Sanchez, J., Kingsbury, C., Nguyen, H., Vandenbark, A. A., Meza-Romero, R., Offner, H. & Borlongan, C. V., Jan 1 2019, (Accepted/In press) In : Translational Stroke Research.

    Research output: Contribution to journal › Article

    • 3 Scopus citations